Cabaletta Bio (NASDAQ:CABA – Free Report) had its price target raised by Cantor Fitzgerald from $40.00 to $50.00 in a research report sent to investors on Wednesday, Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock. Several other equities research analysts also recently weighed in on CABA. Stifel Nicolaus started coverage on […]
Cabaletta Bio (CABA) and Cellares Partner to Evaluate Automated Manufacturing for CABA-201 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned an average recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the […]
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have updated their coverage on the stock in the […]
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $17.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 9.32% from the stock’s current price. A number of […]